CCND1 and neoplasm: Notably, aberrant expression of certain WNTs, inactivating mutations of the APC and AXIN tumor suppressors and oncogenic activating mutations of β-catenin (CTNNB1) have been shown to contribute to cell transformation via deregulation of genes, such as c-MYC and CCND1 (cyclin D1).